Celldex reports Q3 2026 results, confirms 2027 BLA plan for barzolvolimab in CSUNov 5Quarterly updatebarzolvolimabCelldex Therapeutics
Celldex reports Q2 2026 results as barzolvolimab Phase 3 enrollment finishes earlyAug 6Quarterly updatebarzolvolimabCelldex Therapeutics